PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.

Detalles Bibliográficos
Autores principales: Trubkina, Hanna, Iskrou, Ihar, Lendzina, Iryna, Lebedeva, Tatiana, Smolnikova, Viktirya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430242/
http://dx.doi.org/10.1097/01.HS9.0000974916.51447.bd
_version_ 1785090914474000384
author Trubkina, Hanna
Iskrou, Ihar
Lendzina, Iryna
Lebedeva, Tatiana
Smolnikova, Viktirya
author_facet Trubkina, Hanna
Iskrou, Ihar
Lendzina, Iryna
Lebedeva, Tatiana
Smolnikova, Viktirya
author_sort Trubkina, Hanna
collection PubMed
description
format Online
Article
Text
id pubmed-10430242
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104302422023-08-17 PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS. Trubkina, Hanna Iskrou, Ihar Lendzina, Iryna Lebedeva, Tatiana Smolnikova, Viktirya Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430242/ http://dx.doi.org/10.1097/01.HS9.0000974916.51447.bd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Trubkina, Hanna
Iskrou, Ihar
Lendzina, Iryna
Lebedeva, Tatiana
Smolnikova, Viktirya
PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title_full PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title_fullStr PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title_full_unstemmed PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title_short PB2027: EFFICACY OF THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME WITH UNFAVORABLE IMMUNOPHENOTYPIC AND CYTOGENETIC PROGNOSIS.
title_sort pb2027: efficacy of therapy in patients with newly diagnosed myelodysplastic syndrome with unfavorable immunophenotypic and cytogenetic prognosis.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430242/
http://dx.doi.org/10.1097/01.HS9.0000974916.51447.bd
work_keys_str_mv AT trubkinahanna pb2027efficacyoftherapyinpatientswithnewlydiagnosedmyelodysplasticsyndromewithunfavorableimmunophenotypicandcytogeneticprognosis
AT iskrouihar pb2027efficacyoftherapyinpatientswithnewlydiagnosedmyelodysplasticsyndromewithunfavorableimmunophenotypicandcytogeneticprognosis
AT lendzinairyna pb2027efficacyoftherapyinpatientswithnewlydiagnosedmyelodysplasticsyndromewithunfavorableimmunophenotypicandcytogeneticprognosis
AT lebedevatatiana pb2027efficacyoftherapyinpatientswithnewlydiagnosedmyelodysplasticsyndromewithunfavorableimmunophenotypicandcytogeneticprognosis
AT smolnikovaviktirya pb2027efficacyoftherapyinpatientswithnewlydiagnosedmyelodysplasticsyndromewithunfavorableimmunophenotypicandcytogeneticprognosis

Ejemplares similares